These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36125603)
1. The impact of restrictions on psychological outcomes in patients with inflammatory bowel disease on biological treatment during the coronavirus pandemic in Norway. Opheim R; Moum KM; Småstuen MC; Moum B Qual Life Res; 2023 Mar; 32(3):691-699. PubMed ID: 36125603 [TBL] [Abstract][Full Text] [Related]
2. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic. Moum KM; Moum B; Opheim R Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086 [TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 pandemic and lockdown restrictions on psychosocial and behavioural outcomes among Australian adults with type 2 diabetes: Findings from the PREDICT cohort study. Sacre JW; Holmes-Truscott E; Salim A; Anstey KJ; Drummond GR; Huxley RR; Magliano DJ; van Wijngaarden P; Zimmet PZ; Speight J; Shaw JE Diabet Med; 2021 Sep; 38(9):e14611. PubMed ID: 34053106 [TBL] [Abstract][Full Text] [Related]
4. Life changes, self-prevention, knowledge and mental health among inflammatory bowel disease patients during COVID-19 pandemic: a cross-sectional study. He S; Xiao T; Xia Y Front Public Health; 2024; 12():1416880. PubMed ID: 38932786 [TBL] [Abstract][Full Text] [Related]
5. Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey. Nakase H; Wagatsuma K; Nojima M; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Takeuchi K; Tamura S; Kinjo F; Ueno N; Naganuma M; Watanabe K; Moroi R; Nishimata N; Motoya S; Kurahara K; Takahashi S; Maemoto A; Sakuraba H; Saruta M; Tominaga K; Hisabe T; Tanaka H; Terai S; Hiraoka S; Takedomi H; Narimatsu K; Endo K; Nakamura M; Hisamatsu T J Gastroenterol; 2023 Mar; 58(3):205-216. PubMed ID: 36607399 [TBL] [Abstract][Full Text] [Related]
6. Assessing the repercussions of COVID-19 pandemic on symptoms, disease management, and emotional well-being in patients with inflammatory bowel disease: a multi-site survey study. El-Dallal M; Saroufim A; Systrom H; Ballou S; Farhoud A; Pasam RT; Gadupudi SS; Osman K; Chaudrey K; Cheifetz A; Feuerstein JD Scand J Gastroenterol; 2022 Apr; 57(4):406-414. PubMed ID: 34894999 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research. Trindade IA; Ferreira NB Inflamm Bowel Dis; 2021 Jul; 27(8):1224-1229. PubMed ID: 33043977 [TBL] [Abstract][Full Text] [Related]
8. The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic. Wang H; Tu L; Li Y; Bai T; Zou K; Xiao F; Li J; Chen M; Zhang H; Li G; Lu Y; Wang K; Jin S; Yang Y; Zhu L; Hou X J Immunol Res; 2020; 2020():2847316. PubMed ID: 33062719 [TBL] [Abstract][Full Text] [Related]
9. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients. Azzam NA; Aljebreen A; Almuhareb A; Almadi MA Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045 [TBL] [Abstract][Full Text] [Related]
10. Questionnaire-Based Study of 81 Patients in Poland to Evaluate the Course of Inflammatory Bowel Disease and the Effects of the COVID-19 Pandemic on Quality of Life and Mental State from February to June 2021. Owsianko N; Romańczuk-Osenka N; Szczerbakow M; Pikora K; Sowa K; Daniluk U; Rogalski P; Świdnicka-Siergiejko A; Antonowicz S; Krzyżak M; Maślach D; Dąbrowski A; Daniluk J Med Sci Monit; 2022 Nov; 28():e938243. PubMed ID: 36316965 [TBL] [Abstract][Full Text] [Related]
11. The COVID-19 Pandemic Significantly Impacts Pregnancy Planning and Mental Health of Women With Inflammatory Bowel Disease. Tandon P; O'Connor K; Nguyen G; Maxwell C; Huang V J Clin Gastroenterol; 2023 Feb; 57(2):178-184. PubMed ID: 35081079 [TBL] [Abstract][Full Text] [Related]
12. IBD Patients' Perception of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic and Satisfaction with Provided Healthcare: A Cross-Sectional Study. Hrabar D; Cacic P; Biscanin A; Tomasic V; Kralj D; Ogresta D; Pelajic S; Dorosulic Z; Babarovic T Turk J Gastroenterol; 2022 Mar; 33(3):190-195. PubMed ID: 35115285 [TBL] [Abstract][Full Text] [Related]
13. The psychological health of patients diagnosed with cancer in Iraq during the COVID-19 pandemic: A single center study. Alrubai T; Khalil AM; Zaki R; Sinno L; Al Tabbah S Psychooncology; 2022 Apr; 31(4):649-660. PubMed ID: 34751985 [TBL] [Abstract][Full Text] [Related]
14. Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey. Cheema M; Mitrev N; Hall L; Tiongson M; Ahlenstiel G; Kariyawasam V BMJ Open Gastroenterol; 2021 Feb; 8(1):. PubMed ID: 33579729 [TBL] [Abstract][Full Text] [Related]
15. Pediatric inflammatory bowel disease and the effect of COVID-19 pandemic on treatment adherence and patients' behavior. Dorfman L; Nassar R; Binjamin Ohana D; Oseran I; Matar M; Shamir R; Assa A Pediatr Res; 2021 Sep; 90(3):637-641. PubMed ID: 33446913 [TBL] [Abstract][Full Text] [Related]
16. Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease. Paulides E; Pasma A; Erler NS; van Eijk RLA; de Vries AC; van der Woude CJ Dig Dis Sci; 2022 Jul; 67(7):2849-2856. PubMed ID: 34181168 [TBL] [Abstract][Full Text] [Related]
17. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review. Dubinsky MC; Dotan I; Rubin DT; Bernauer M; Patel D; Cheung R; Modesto I; Latymer M; Keefer L Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):985-997. PubMed ID: 34130572 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory Bowel Disease Management in a Romanian Tertiary Gastroenterology Center: Challenges of the COVID-19 Pandemic. Vadan R; Iacob R; Costache R; Stroie T; Saizu IA; Iacob S; Gheorghe L; Diculescu M; Gheorghe C J Gastrointestin Liver Dis; 2020 Dec; 29(4):549-553. PubMed ID: 33331349 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients' Perspective. Grunert PC; Reuken PA; Stallhofer J; Teich N; Stallmach A J Crohns Colitis; 2020 Dec; 14(12):1702-1708. PubMed ID: 32564068 [TBL] [Abstract][Full Text] [Related]
20. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]